Cite
APA Citation
Butzkueven, H., Trojano, M., Kappos, L., Spelman, T., Wiendl, H., Rosales, K., Su, R., Licata, S., Ho, P., & Campbell, N. (2021). clinical outcomes in patients who discontinue natalizumab therapy after 2 years in the Tysabri® Observational Program (TOP). Multiple sclerosis, 27, 410–419. http://access.bl.uk/ark:/81055/vdc_100116339056.0x00000f